PLRZ net incomeFY2025-$3.33M
PLRZ net income was -$3.33M for fiscal 2025 (ended Dec 31, 2025), compared with -$1.54M in fiscal 2024.
For fiscal 2025 (ended Dec 31, 2025), Polyrizon Ltd. reported -$3.33M of net income.
PLRZ net income was -$3.33M for fiscal 2025 (ended Dec 31, 2025), compared with -$1.54M in fiscal 2024.
PLRZ diluted EPS was $4.90 for fiscal 2025 (ended Dec 31, 2025).
PLRZ free cash flow was -$4.54M for fiscal 2025 (ended Dec 31, 2025).
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Research and development | $2.13M | $534.0K | $332.0K | $347.0K |
| Selling, general and admin | $4.12M | $768.0K | $303.0K | $548.0K |
| Operating income | -$6.25M | -$1.30M | -$635.0K | -$895.0K |
| Net income | -$3.33M | -$1.54M | -$600.0K | -$779.0K |
| EPS, basic | $4.90 | $805.20 | $494.40 | $0.60 |
| EPS, diluted | $4.90 | $805.20 | $494.40 | $0.60 |
| Diluted shares | 680,380 | 1,994 | 1,354 | 1.3M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Cash and equivalents | $1.31M | $2.55M | $4.0K | $36.0K |
| Short-term investments | - | - | $37.0K | - |
| Current assets | $12.86M | $2.65M | $54.0K | - |
| Total assets | $21.44M | $5.55M | $559.0K | - |
| Current liabilities | $443.0K | $261.0K | $502.0K | - |
| Shareholders' equity | $20.99M | $5.29M | -$191.0K | -$900.0K |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | -$4.53M | -$1.15M | -$537.0K | -$1.13M |
| Capital expenditures | $7.0K | - | - | $3.0K |
| Free cash flow | -$4.54M | - | - | -$1.14M |
| Investing cash flow | -$16.53M | $29.0K | - | -$3.0K |
| Financing cash flow | $19.81M | $3.67M | $505.0K | $648.0K |
| Stock-based compensation | $1.31M | $51.0K | $100.0K | $130.0K |
Source: XBRL data Polyrizon Ltd. files with the SEC, latest filing dated Mar 25, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| PLRZ | - | - | -$3.33M | - | $26.8M |
| SYK | $26.30B | +7.9% | $3.62B | 13.8% | $124.00B |
| MMM | $25.25B | +1.7% | $3.54B | 14.0% | $97.47B |
| BSX | $21.07B | +8.9% | $3.50B | 16.6% | $63.81B |
| BDX | $23.25B | +17.4% | $941.00M | 4.0% | $58.63B |
| MDLN | $30.68B | - | $683.00M | 2.2% | $53.55B |
| RMD | $5.73B | +9.0% | $1.59B | 27.8% | $33.16B |
| DXCM | $5.10B | +13.0% | $991.00M | 19.4% | $30.24B |
| WST | $3.40B | +12.6% | $638.90M | 18.8% | $28.78B |